Pharmacogenomics in pediatric leukemia.

Pharmacogenomics in pediatric leukemia.

Item
http://www.wikidata.org/entity/Q36727952
Using germline genomics to individualize pediatric cancer treatmentsPharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapyThe Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.New agents for the treatment of lymphoid leukemia and lymphoma: focus on recent FDA approvals.Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?Cancer pharmacogenomicsMultilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia.Cancer pharmacogenomics in children: research initiatives and progress to date.Risk factors for relapse in childhood acute lymphoblastic leukemia: prediction and prevention.Clinically relevant pharmacogenomic testing in pediatric practice.Pharmacogenetics, cost of genotyping, and guidelines for individualizing therapy with mercaptopurine in pediatric acute lymphoblastic leukemia.
P2860

Pharmacogenomics in pediatric leukemia.

Item
http://www.wikidata.org/entity/Q36727952
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Pharmacogenomics in pediatric leukemia.
@ast
Pharmacogenomics in pediatric leukemia.
@en
type
label
Pharmacogenomics in pediatric leukemia.
@ast
Pharmacogenomics in pediatric leukemia.
@en
prefLabel
Pharmacogenomics in pediatric leukemia.
@ast
Pharmacogenomics in pediatric leukemia.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Pharmacogenomics in pediatric leukemia.
@en
P2093
P2860
P304
P31
P356
10.1097/MOP.0B013E32833FDE85
P433
P478
P577
P698
P921
P932